MoneyWorks4Me

Aurobindo Pharma informs about disclosure

02 May 2024 Evaluate

With reference to its letter dated February 5, 2024, informing about disposal of business assets of Eugia US Manufacturing LLC, a wholly owned step- down subsidiary of the Company. In this regard, Aurobindo Pharma has informed that the aforementioned disposal of business assets has been completed on May 1, 2024.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1630.10 -0.90 (-0.06%)
28-Aug-2026 10:43 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1913.40
Dr. Reddys Labs. 1181.60
Cipla 1412.50
Lupin 2158.30
Zydus Lifesciences 1181.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: